Reference drug programs: Effectiveness and policy implications

This publication has 50 references indexed in Scilit:

• Evaluating Short-Term Drug Effects Using a Physician-Specific Prescribing Preference as an Instrumental Variable
  Epidemiology, 2006
• Reference Pricing For Drugs: Is It Compatible With U.S. Health Care?
  Health Affairs, 2003
• Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
  JAMA, 2002
• Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
  JAMA, 2002
• Medicare and Prescription Drugs
  New England Journal of Medicine, 2001
• The Medicare Prescription Drug Benefit: How Will The Game Be Played?
  Health Affairs, 2000
• What is Germany's experience on reference based drug pricing and the etiology of adverse health outcomes or substitution?
  Health Policy, 1998
• Consequences of Implementing a Drug Budget for Office-Based Physicians in Germany
  PharmacoEconomics, 1996
• Effects of Limiting Medicaid Drug-Reimbursement Benefits on the Use of Psychotropic Agents and Acute Mental Health Services by Patients with Schizophrenia
  New England Journal of Medicine, 1994
• Payment Restrictions for Prescription Drugs under Medicaid
  New England Journal of Medicine, 1987